Penthrox® (Methoxyflurane) as an Analgesic for Removal of Circular External Fixators and Minor Procedures during the COVID-19 Pandemic.

IF 1 Q3 ORTHOPEDICS
Ekansh Debuka, Patrick Birkenhead, Sohan Shah, Badri Narayan, Nikolaos Giotakis, Phillipa Thorpe, Simon Matthew Graham, Benjamin E Fischer, Nick Peterson
{"title":"Penthrox<sup>®</sup> (Methoxyflurane) as an Analgesic for Removal of Circular External Fixators and Minor Procedures during the COVID-19 Pandemic.","authors":"Ekansh Debuka, Patrick Birkenhead, Sohan Shah, Badri Narayan, Nikolaos Giotakis, Phillipa Thorpe, Simon Matthew Graham, Benjamin E Fischer, Nick Peterson","doi":"10.5005/jp-journals-10080-1587","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Methoxyflurane has excellent analgesic properties and is approved for use in the United Kingdom and Ireland since 2015. It is currently used in emergency departments for analgesia during fracture reductions. During the COVID-19 pandemic, with theatre access severely restricted, Penthrox® had the potential to provide adequate pain relief to aid frame and wire removal in the clinic setting.</p><p><strong>Materials and methods: </strong>Patients presenting to the limb reconstruction service elective clinic and requiring frame removal or minor procedures were included in the study. Patients with renal, cardiac or hepatic disease, a history of sensitivity to fluorinated anaesthetic agents and those on any nephrotoxic or enzyme-inducing drugs were excluded. All procedures were performed in an appropriate isolated room in the clinic. Patient demographics, procedure details, visual analogue score, Richmond Agitation Scale and patient satisfaction were recorded.</p><p><strong>Results: </strong>A total of 39 patients were included in the study of which 17 had Ilizarov frames removed, 10 had hexapod removals, nine had heel rings removed and three had an external fixator removed. Eleven patients received additional pain relief in the form of oral analgesia. All patients were satisfied or very satisfied with the experience. One patient required a general anaesthetic for the removal of a wire that could not be removed in the clinic due to bony overgrowth.</p><p><strong>Conclusion: </strong>Patient satisfaction was very high (>95%), and it was possible to perform frame removals and minor procedures in the clinic environment during the COVID-19 pandemic. We see potential for regular use of Penthrox® in the future for the removal of external fixation outside of the operating theatre.</p><p><strong>Clinical significance: </strong>Penthrox as an analgesic for frame adjustments and removals is safe and has the potential for significant financial savings for the National Health Service (NHS).</p><p><strong>How to cite this article: </strong>Debuka E, Birkenhead P, Shah S, <i>et al</i>. Penthrox® (Methoxyflurane) as an Analgesic for Removal of Circular External Fixators and Minor Procedures during the COVID-19 Pandemic. Strategies Trauma Limb Reconstr 2023;18(2):82-86.</p>","PeriodicalId":21979,"journal":{"name":"Strategies in Trauma and Limb Reconstruction","volume":"18 2","pages":"82-86"},"PeriodicalIF":1.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628611/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Strategies in Trauma and Limb Reconstruction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10080-1587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Methoxyflurane has excellent analgesic properties and is approved for use in the United Kingdom and Ireland since 2015. It is currently used in emergency departments for analgesia during fracture reductions. During the COVID-19 pandemic, with theatre access severely restricted, Penthrox® had the potential to provide adequate pain relief to aid frame and wire removal in the clinic setting.

Materials and methods: Patients presenting to the limb reconstruction service elective clinic and requiring frame removal or minor procedures were included in the study. Patients with renal, cardiac or hepatic disease, a history of sensitivity to fluorinated anaesthetic agents and those on any nephrotoxic or enzyme-inducing drugs were excluded. All procedures were performed in an appropriate isolated room in the clinic. Patient demographics, procedure details, visual analogue score, Richmond Agitation Scale and patient satisfaction were recorded.

Results: A total of 39 patients were included in the study of which 17 had Ilizarov frames removed, 10 had hexapod removals, nine had heel rings removed and three had an external fixator removed. Eleven patients received additional pain relief in the form of oral analgesia. All patients were satisfied or very satisfied with the experience. One patient required a general anaesthetic for the removal of a wire that could not be removed in the clinic due to bony overgrowth.

Conclusion: Patient satisfaction was very high (>95%), and it was possible to perform frame removals and minor procedures in the clinic environment during the COVID-19 pandemic. We see potential for regular use of Penthrox® in the future for the removal of external fixation outside of the operating theatre.

Clinical significance: Penthrox as an analgesic for frame adjustments and removals is safe and has the potential for significant financial savings for the National Health Service (NHS).

How to cite this article: Debuka E, Birkenhead P, Shah S, et al. Penthrox® (Methoxyflurane) as an Analgesic for Removal of Circular External Fixators and Minor Procedures during the COVID-19 Pandemic. Strategies Trauma Limb Reconstr 2023;18(2):82-86.

Abstract Image

Abstract Image

Abstract Image

Penthrox®(甲氧基氟烷)作为一种镇痛药,用于在新冠肺炎大流行期间移除环形外固定器和小程序。
简介:甲氧基氟烷具有优异的镇痛性能,自2015年起被批准在英国和爱尔兰使用。目前,它在急诊科用于骨折复位期间的镇痛。在新冠肺炎大流行期间,由于手术室通道受到严重限制,Penthrox®有可能提供足够的疼痛缓解,以帮助在临床环境中移除框架和金属丝。材料和方法:在肢体重建服务选择性诊所就诊并需要进行框架切除或小手术的患者被纳入研究。排除患有肾脏、心脏或肝脏疾病、有氟化麻醉剂敏感史以及服用任何肾毒性或酶诱导药物的患者。所有手术都是在诊所的一个适当的隔离房间里进行的。记录患者人口统计、手术细节、视觉模拟评分、Richmond激动量表和患者满意度。结果:共有39名患者被纳入研究,其中17名患者移除了Ilizarov支架,10名患者移除六足,9名患者移除足跟环,3名患者移除外固定器。11名患者接受了口服镇痛的额外疼痛缓解。所有患者都对这次经历感到满意或非常满意。一名患者需要全身麻醉才能取出因骨质过度生长而无法在诊所取出的金属丝。结论:患者满意度非常高(>95%),在新冠肺炎大流行期间,可以在临床环境中进行框架拆除和小程序。我们看到了将来定期使用Penthrox®在手术室外移除外固定的潜力。临床意义:Penthrox作为一种用于框架调整和移除的镇痛药是安全的,并有可能为国家医疗服务体系(NHS)节省大量资金。如何引用本文:Debuka E,Birkenhead P,Shah S等人。Penthrox®(甲氧基氟烷)作为新冠肺炎大流行期间环形外固定器移除和小程序的镇痛药。2023年创伤肢体康复策略;18(2):82-86。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Strategies in Trauma and Limb Reconstruction
Strategies in Trauma and Limb Reconstruction Medicine-Orthopedics and Sports Medicine
CiteScore
1.50
自引率
0.00%
发文量
31
期刊介绍: Strategies in Trauma and Limb Reconstruction is dedicated to surgeons, allied medical professionals and researchers in the field of orthopaedics and trauma. The scope of the journal is to discuss the fields of skeletal injury, and the complications thereof, congenital and acquired limb deformities and deficiencies, and orthopaedic-related infection, together with their surgical and non-surgical treatments. The journal publishes original articles, reviews, case reports, descriptions of new or recognised treatment techniques, forum discussions of clinical scenarios and relevant correspondence. It aims to provide a widely accessible source of useful information to practitioners in the field through the problem- or technique-based approach of published articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信